16 05, 2023 Daniela Massi et al., Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group. adlitterio663392023-10-17T09:13:02+02:00 Leggi di più
10 02, 2023 Federica Zannier et al., Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma adlitterio663392023-10-31T16:22:19+01:00 Leggi di più
21 11, 2022 Jonathan E Thompson, Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in veterinary medicine: Recent advances (2019-present). adlitterio663392023-05-26T12:26:10+02:00 Leggi di più
1 09, 2022 Alessandro Dal Maso et al., EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience adlitterio663392022-10-20T11:47:26+02:00 Leggi di più
25 04, 2022 Lucrezia Togni et al., Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis adlitterio663392022-10-20T12:26:11+02:00 Leggi di più
9 10, 2021 Francesca Signorini et al., Conventional Transbronchial Needle Aspiration (cTBNA) and EBUS-Guided Transbronchial Needle Aspiration (EBUS-TBNA): A Retrospective Study on the Comparison of the Two Methods for Diagnostic Adequacy in Molecular Analysis adlitterio663392022-10-21T08:55:06+02:00 Leggi di più
23 09, 2021 Paola Ulivi et al., Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience adlitterio663392022-10-14T12:06:12+02:00 Leggi di più
21 09, 2021 Carla Debernardi et al., Correction to: Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction adlitterio663392022-10-21T09:22:20+02:00 Leggi di più
19 08, 2021 Sabrina Rossi et al., Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC adlitterio663392022-10-21T09:20:24+02:00 Leggi di più
18 07, 2021 Alessandro Parisi et al., Clinicians’ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, “Real-Life”, Case-Control Study adlitterio663392022-10-21T09:31:52+02:00 Leggi di più